Artemis Initial Financing Will Broaden Genomics Platform With Exelixis
Executive Summary
Cologne, Germany-based genomics firm Artemis' initial $8.8 mil. (DM 15 mil.) round of financing will be used to help develop a "comprehensive technology package" with minority shareholder Exelixis of San Francisco, Calif.